Overview

Effects of Exenatide on Motor Function and the Brain

Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to investigate how the brain and motor behavior changes Parkinson's Disease (PD) over time in response to Exenatide. In previous clinical trials, PD patients have experienced symptomatic improvement on Exenatide and literature suggests it may help slow the progression of Parkinson's. Both will be evaluated in this study.
Phase:
Phase 1
Details
Lead Sponsor:
University of Florida
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Exenatide
Glucagon
Glucagon-Like Peptide 1